Compare Natera Inc. Common Stock (NTRA) vs Pinterest Inc (PINS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Natera Inc. Common Stock vs Pinterest Inc — how do they compare? Natera Inc. Common Stock trades at $393.93 (market cap $57.03B), while Pinterest Inc trades at $21.75 (market cap $12.32B). The key difference: Natera Inc. Common Stock is far larger — about 4.6× Pinterest Inc's market cap, and Natera Inc. Common Stock is trading nearer its 52-week high, Pinterest Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Natera Inc. Common Stock for 0 Days and Pinterest Inc for 85 Days on average.
| NTRA | PINS | |
|---|---|---|
Market Cap | $57.03B | $12.32B |
Volume | 1,131,157 | 10,523,209 |
Sector | Health | Media |
52-Week High | $425.64 | $35.24 |
52-Week Low | $179.42 | $15.42 |
Typical Hold Time | 0 Days | 85 Days |
Enterprise Value | $56.18B | $12.24B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
NTRA trades at $395.66, down 0.53% today but remains near recent highs. The stock shows mixed technical signals with neutral momentum indicators. Fundamentally, the company demonstrates strong revenue growth ($2.31B in 2025, projected $2.7B in 2026) but continues to operate at a net loss (-$208M in 2025). Recent positive developments include FDA Breakthrough Device designation for its multi-cancer detection assay and regulatory approval in Japan for Signatera.
NTRA presents a growth story with significant analyst support (89% buy ratings) but carries execution risks. The stock trades at premium valuations (P/S 20.48) while still unprofitable. Key catalysts include clinical trial progress and international expansion, though investors face risks from ongoing losses and competitive pressures in precision medicine.
Pinterest (PINS) trades at $22.36, up 4.37% today, showing strong momentum after recent earnings beats. The stock maintains a bullish technical outlook with consistent revenue growth from $2.8B in 2022 to $4.2B in 2025. Analyst consensus is strongly positive with 54% buy ratings and a $27.93 price target, representing 25% upside potential. Recent news highlights Pinterest's visual search ads launch and international monetization growth as key catalysts.
The outlook remains favorable with strong fundamentals and technical momentum, though elevated valuation ratios (P/E 65.8) and insider selling present near-term risks. Revenue growth continues at 15%+ annually while profit margins improved from negative to 9.9% in 2025. Competition in digital advertising and market volatility are key watchpoints for investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Natera Inc. Common Stock
Natera, Inc. develops and provides cell-free DNA-based genetic testing across women's health, oncology, organ health, and rare disease, with flagship products including Panorama for noninvasive prenatal screening and Signatera for cancer recurrence monitoring.
Read more on NTRA →About Pinterest Inc
Pinterest is an online product and idea discovery platform that helps users gather ideas on everything from recipes to cook to destinations to travel to. Founded in 2010, the platform consists of a largely female audience, at roughly two thirds of its more than 365 million monthly active users. The company generates revenue by selling digital ads and is now rolling out more in-platform e-commerce features.
Read more on PINS →
